MGMT encodes a repair protein which removes alkyl groups from the O6-position of guanine residues [49] and its promoter methylation has been described as a biomarker in several studies, especially for glioblastoma [50] and colorectal cancer [51]. The gene discussed is MGMT; the disease is glioblastoma.